Efficacy of Icosapent Ethyl for Cardiovascular Risk Reduction by Aspirin Use in REDUCE-IT
Aggarwal Rahul, Steg Philippe, Bhatt Deepak, Ballantyne Christie, Miller Michael, Brinton Eliot, Jacobson Terry, Ketchum Steven, Doyle Ralph, Tardif Jean-claude
Substantial cardiovascular risk reduction with icosapent ethyl in patients with prior cardiovascular events regardless of coronary artery disease history: REDUCE-IT CAD
Aggarwal Rahul, Tardif Jean-claude, Steg Philippe, Bhatt Deepak, Ballantyne Christie, Miller Michael, Brinton Eliot, Jacobson Terry, Ketchum Steven, Lira Pineda Armando, Doyle Ralph